Mobile App

Google Play Apple Store
A Rheumatologist’s Perspective on Pulmonary Arterial Hypertension
Certified CME/CNE/CPE Activity - Mini Modules
Pulmonary arterial hypertension (PAH) is a leading cause of death in connective tissue disorders. Early recognition and referral are key to preventing clinical worsening and death.

These educational Mini Modules™ will review the epidemiology, pathophysiology, and diagnostic strategies of PAH in patients with connective tissue disease. Additionally, a comparative analysis of current treatment options is featured, as well as a discussion of new drugs in development and/or recent clinical data on treatments for PAH in patients with connective tissue disorders.

Updated information is noted on the slide in the upper right hand corner. Please note that participants who have previously claimed credit for this activity should not claim duplicate credit based on the updates.

Review one (or all) Mini Modules of interest. Claim 0.5 AMA, ANCC, or ACPE credit/contact hour(s) per module after completion of each brief Post-Test/Evaluation.
James R. Seibold, MD
James R. Seibold, MD
President
Scleroderma Research Consultants, LLC

Virginia D. Steen, MD
Virginia D. Steen, MD
Professor of Medicine
Georgetown University




 


*This coverage is not sanctioned by the conference organizers and is not an official part of the conference proceedings of CHEST 2015
20

Supported by an independent educational grant from
Gilead Sciences Medical Affairs,
United Therapeutics
and its subsidiary, Lung Biotechnology

Expired Activity
Mini Module
6070
MiniModules_WebBanner.RA(1150).gif
Rheumatology